🔎 Trials Near Me

Akèy › Twoub depresif majè › Illinois › Chicago

Etid klinik pou Twoub depresif majè nan Chicago, IL

17 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Charter Research - Chicago, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Chicago Research Center, Chicago
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • Northwestern University, Chicago
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 2
  • Chicago Research Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • Rush University, Chicago
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • Vanda Investigational Site, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06830044

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • Rush University Medical Center, Chicago
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Ap rekriteFaz 3
  • Uptown Research Institute, Chicago
Laj 18 a 74 · Tout sèks · Mizajou Aug 10, 2026 · NCT07592689

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • EmVenio Research, Chicago
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 2
  • Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Jun 15, 2026 · NCT07276997

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Ap rekrite
  • University of Illinois at Chicago, Chicago
Laj 18 a 64 · Tout sèks · Mizajou Jun 4, 2026 · NCT05051618

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Ap rekriteFaz 2
  • Pillar Clinical Research LLC, Chicago
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Ap rekriteEtid obsèvasyon
  • University of Chicago Medical Center, Chicago
Laj 18 a 40 · Tout sèks · Mizajou Mar 10, 2026 · NCT06740383

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 310, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.